Minnal Gupta

Medicine · Health Sciences

19h-index7.4kcitations38works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(32), Immunotherapy and Immune Responses(12), Multiple Myeloma Research and Treatments(8), Virus-based gene therapy research(6), Immune Cell Function and Interaction(6)

Publications38 total

Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2025Open Access
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023Open Access
Data from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023Open Access
Data from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023· 1 citedOpen Access
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023Open Access
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
Nature·2022· 6 citedOpen Access
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
Blood Cancer Discovery·2022· 69 citedOpen Access
Abstract 66: A multi-institution examination of concordance in spatial transcriptomics using the GeoMx Cancer Transcriptome Atlas
Cancer Research·2022
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response
Frontiers in Immunology·2022· 30 citedOpen Access
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Nature Medicine·2022· 456 citedOpen Access
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
Nature·2022· 853 citedOpen Access
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
Journal of Clinical Investigation·2021· 88 citedOpen Access
Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cells
2021· 1 citedOpen Access
Decade-long remissions of leukemia sustained by the persistence of activated CD4 <sup>+</sup> CAR T-cells
2021· 2 citedOpen Access
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Nature Medicine·2021· 23 citedOpen Access
CRISPR-engineered T cells in patients with refractory cancer
Science·2020· 1.4k citedOpen Access
Study on immune response to intravesical Bacillus Calmette Guerine in non-muscle invasive bladder cancer
European Urology Supplements·2019
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
OncoImmunology·2019· 63 citedOpen Access
Long-Term Remission of CLL Sustained By Pauciclonal Anti-CD19 Chimeric Antigen Receptor T (CTL019) Cell Clones
Blood·2018· 4 cited
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Nature·2018· 830 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Carl H. June(33), Irina Kulikovskaya(32), Simon F. Lacey(29), Bruce L. Levine(22), J. Joseph Melenhorst(18), Edward A. Stadtmauer(18), Joseph A. Fraietta(17), Regina M. Young(17), Lifeng Tian(16), Dan T. Vogl(16), David E Ambrose(13), Wei‐Ting Hwang(12), Jennifer L. Brogdon(12), Vanessa Gonzalez(12), Gabriela Plesa(12), Noelle V. Frey(11), Alfred L. Garfall(11), David L. Porter(10), Adam D. Cohen(10), Brendan M. Weiss(10)